Lori Lyons-Williams - 30 Jan 2026 Form 4 Insider Report for RAPT Therapeutics, Inc. (RAPT)

Role
Director
Signature
/s/ Rodney Young, Attorney-in-Fact
Issuer symbol
RAPT
Transactions as of
30 Jan 2026
Net transactions value
$0
Form type
4
Filing time
02 Feb 2026, 17:47:51 UTC
Previous filing
26 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lyons-Williams Lori Director C/O RAPT THERAPEUTICS, INC., 561 ECCLES AVENUE, SOUTH SAN FRANCISCO /s/ Rodney Young, Attorney-in-Fact 02 Feb 2026 0001693564

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RAPT Common Stock Award $0 +4,956 $0.000000 4,956 30 Jan 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the annual grant of restricted stock units ("RSUs") under the Issuer's Amended & Restated Non-Employee Director Compensation Policy, as currently in effect, which fully vest on the first anniversary of the grant date. Each RSU represents a contingent right to receive one share of common stock upon vesting.